Evidence map›Paper›PMID 31600082›Full record

ArticleThe British journal of radiology2020

An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology.

Miranda P Lawell, Daniel J Indelicato, Arnold C Paulino, William Hartsell, Nadia N Laack, Ralph P Ermoian, John P Perentesis, Ralph Vatner, Stephanie Perkins, Victor S Mangona and 16 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The British journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Evidence-based indications for proton therapy in adults determined using the GRADE approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Proton therapy special feature: introductory editorial.The British journal of radiology · 2020
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 1 country.

Miranda P LawellDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Daniel J IndelicatoDepartment of Radiation Oncology, University of Florida, Gainesville, United States.
Arnold C PaulinoDepartment of Radiation Oncology, MD Anderson Cancer Center, Houston, United States.
William HartsellDepartment of Radiation Oncology, Northwestern Medicine Chicago Proton Center, Warrenville, United States.
Nadia N LaackDepartment of Radiation Oncology, Mayo Clinic, Rochester, United States.
Ralph P ErmoianDepartment of Radiation Oncology, University of Washington, Seattle, United States.
John P PerentesisDivision of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States.
Ralph VatnerDepartment of Radiation Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States.
Stephanie PerkinsDepartment of Radiation Oncology, Washington University, St. Louis, United States.
Victor S MangonaDepartment of Radiation Oncology, Texas Center for Proton Therapy, Irving, United States.
Christine E Hill-KayserDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, United States.
Suzanne L WoldenDepartment of Radiation Oncology, ProCure Proton Therapy Center, New Jersey, United States.
Young KwokDepartment of Radiation Oncology, University of Maryland, College park, United States.
John Han-Chih ChangDepartment of Radiation Oncology, Oklahoma Proton Therapy Center, Oklahoma, United States.
J Ben WilkinsonDepartment of Radiation Oncology, Provision Healthcare, Knoxville, United States.
Iain MacEwanDepartment of Radiation Oncology, California Protons Cancer Therapy Center, San Diego, United States.
Andrew L ChangDepartment of Radiation Oncology, California Protons Cancer Therapy Center, San Diego, United States.
Bree R EatonDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, United States.
Matthew M LadraDepartment of Pediatric Radiation Oncology, John Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, Washington, United States.
Sara L GallottoDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Elizabeth A WeymanDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Benjamin V M BajajDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Sujith BaligaDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Beow Y YeapDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Amy Berrington de GonzalezRadiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer InstituteNational Institutes of Health, Bethesda, United States.
Torunn I YockDepartment of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, United States.
Massachusetts General Hospital · USHarvard University · USCincinnati Children's Hospital Medical Center · USDivision of Cancer Epidemiology and GeneticsEmory University · USMayo Clinic · USNorthwestern Medicine · USProCure (United States) · USProvision Healthcare · USSeattle University · USSidney Kimmel Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Florida · USUniversity of Maryland, College Park · USUniversity of Pennsylvania · USWashington University in St. Louis · US

Funding

Studies of Populations Exposed to Therapeutic Medical Radiation and Other AgentsZIACP010131 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MORTON, LINDSAY · 2009 to 2025
$81.0M
6 · The paper itself

Abstract

objectiveThe Pediatric Proton/Photon Consortium Registry (PPCR) is a comprehensive data registry composed of pediatric patients treated with radiation. It was established to expedite outcomes-based research. The attributes which allow the PPCR to be a successful collaboration are reviewed. METHODS AND MATERIALS: Current eligibility criteria are radiotherapy patients < 22 years treated at one of the 15 US participating institutions. Detailed health and treatment data are collected about the disease presentation and treatment exposures, and annually thereafter, in REDCap (Research Electronic Data Capture). DICOM (Digital Imaging and Communications in Medicine) imaging and radiation plans are collected through MIM/MIMcloud. An optional patient-reported quality-of-life (PedsQL) study is administered at 10 sites.

resultsAccrual started October 2012 with 2,775 participants enrolled as of 25 July 2019. Most patients, 62.0%, were treated for central nervous system (CNS) tumors, the most common of which are medulloblastoma (

conclusionsThe PPCR is a valuable research platform capable of answering countless research questions that will ultimately improve patient care. Centers outside of the USA are invited to participate directly or may engage with the PPCR to align data collection strategies to facilitate large-scale international research. ADVANCES IN KNOWLEDGE: For investigators looking to carry out research in a large pediatric oncology cohort or interested in registry work, this paper provides an updated overview of the PPCR.

Indexed as

AdolescentAstrocytomaCentral Nervous System NeoplasmsCerebellar NeoplasmsChildChild, PreschoolCloud ComputingData CollectionEpendymomaFemaleGliomaHumansInfantInternational CooperationMaleMedulloblastoma

Identifiers

PMID31600082
PMCPMC7066966
OpenAlexW2979904110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.